"I certainly agree with you when you say our share price won't move higher till we get human trial results. I think we'll be re-rated as soon as we get burns trials back (assuming they're positive)"
This 100% I dont mind if the share price remains here while we wait. Human data will be a huge catalyst.
Things we are waiting on:
1. Burns trial data 2. IV trial commencing and data 3. COVID19 animal testing in the USA 4. R435 preclinical data from Dr Sutton at MCRI
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)